Exploration of Pyrazolo[1,5‐<i>a</i>]pyrimidines as Membrane‐Bound Pyrophosphatase Inhibitors
Niklas G. Johansson, Loïc Dreano, Keni Vidilaseris, Ayman Khattab, Jianing Liu, Arthur Lasbleiz, Orquídea Ribeiro, Alexandros Kiriazis, Gustav Boije af Gennäs, Seppo Meri, Adrian Goldman, Jari Yli‐Kauhaluoma, Henri Xhaard
Abstract
Inhibition of membrane-bound pyrophosphatase (mPPase) with small molecules offer a new approach in the fight against pathogenic protozoan parasites. mPPases are absent in humans, but essential for many protists as they couple pyrophosphate hydrolysis to the active transport of protons or sodium ions across acidocalcisomal membranes. So far, only few nonphosphorus inhibitors have been reported. Here, we explore the chemical space around previous hits using a combination of screening and synthetic medicinal chemistry, identifying compounds with low micromolar inhibitory activities in the Thermotoga maritima mPPase test system. We furthermore provide early structure-activity relationships around a new scaffold having a pyrazolo[1,5-a]pyrimidine core. The most promising pyrazolo[1,5-a]pyrimidine congener was further investigated and found to inhibit Plasmodium falciparum mPPase in membranes as well as the growth of P. falciparum in an ex vivo survival assay.